Why Publish with The Journal of Infectious Diseases?
Published continuously since 1904, The Journal of Infectious Diseases (JID) is the premier global journal for translational infectious diseases science and is an official publication of the Infectious Diseases Society of America. The editors welcome Major Articles and Brief Reports describing research results on microbiology, immunology, epidemiology, and related disciplines; on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune responses. With an Impact Factor of 5.0, the journal is ranked 15 out of 132 journals in the field of infectious diseases.
Fast Publication Speed
Manuscripts are first published within 24-72 hours of acceptance; corrected proofs are published within 3-5 weeks.
Ease of Submission
The journal offers format free submissions, as well as an efficient transfer process to Clinical Infectious Diseases or Open Forum Infectious Diseases.
Distinguished Editorial Board
Members of the JID Editorial Board are recruited and appointed based on their expertise in the field. The board ensures the journal publishes high-quality content, operates ethically, and provides a welcoming publishing outlet for authors from all backgrounds and at all career stages.
Meet JID’s Editor-in-Chief
Discoverability
Authors publishing in the journal benefit from a wide array of services to help support discoverability, including OUP’s platform capabilities, self-promotion tools, and IDSA’s social media and other communications vehicles, including JID’s X presence. With an average of more than 250,000 visits with content engagement per month, your article will receive significant exposure.
Open Access
If you prefer to make your work available under an open access license, or your funder requires open access publication, JID offers these options.